...
首页> 外文期刊>Journal of Materials Chemistry, B. materials for biology and medicine >Silica-assisted incorporation of polydopamine into the framework of porous nanocarriers by a facile one-pot synthesis
【24h】

Silica-assisted incorporation of polydopamine into the framework of porous nanocarriers by a facile one-pot synthesis

机译:通过简便的一锅合成法将二氧化硅辅助将聚多巴胺掺入多孔纳米载体的框架中

获取原文
获取原文并翻译 | 示例
           

摘要

Mussel-inspired polydopamine (PDA), with its advanced bio-adhesive properties, has shown great potential in drug delivery based on host-guest interaction. However, it is difficult to synthesize PDA NPs of high surface area using the traditional polymerization of dopamine monomers in an alkaline solution. Taking advantage of the interaction between PDA and silicic acid inspired by biosilicification, PDA was rendered with high surface area in 70 nm-sized hybrid porous particles by a silica assisted one-pot preparation. PDA building blocks were successfully incorporated into the silica framework by controlled addition of dopamine (1.25-5 mol% with respect to the silica source) in a typical synthesis of mesoporous silica nanoparticles (MSNs). It is revealed that the cooperative molecular interaction between silicic acid and catechol groups of PDA results in a retardation of the silica condensation during the particle formation process. Moreover, the replacement of dopamine with polyphenols such as epigallocatechin gallate (EGCG) or tannic acid (TA) resulted in complete phase separation of the polymer and silica at the same molar ratio, suggesting the important role of amines in PDA towards stable hybridization in the particles. The application potential of the PDA-MSN hybrid nanocarriers is demonstrated by an unprecedentedly high drug (DOX) loading capacity of 1000 mg g(-1), a sustained drug release, as well as enhanced killing efficiency of cancer cells at low dosage. These findings are expected to inspire strategies and pave a way for utilizing PDA for constructing organic-inorganic composite nanocarriers.
机译:贻贝启发的聚多巴胺(PDA)具有先进的生物粘附特性,在基于宿主-客体相互作用的药物递送中显示出巨大潜力。但是,使用碱性溶液中的多巴胺单体的传统聚合方法难以合成高表面积的PDA NP。利用生物硅化作用启发的PDA和硅酸之间的相互作用,通过二氧化硅辅助的一锅法制备,在70 nm尺寸的杂化多孔颗粒中使PDA具有高表面积。通过在典型的介孔二氧化硅纳米粒子(MSNs)合成中,通过控制添加多巴胺(相对于二氧化硅源为1.25-5 mol%),将PDA结构单元成功地引入到二氧化硅骨架中。揭示了硅酸和PDA的儿茶酚基团之间的协同分子相互作用导致在颗粒形成过程中二氧化硅缩合的延迟。此外,用多酚如表没食子儿茶素没食子酸酯(EGCG)或单宁酸(TA)代替多巴胺可导致在相同摩尔比下聚合物和二氧化硅完全相分离,这表明胺在PDA中对稳定杂交具有重要作用。粒子。 PDA-MSN杂化纳米载体的应用潜力通过空前的1000 mg g(-1)的高药物(DOX)负载能力,持续的药物释放以及低剂量时增强的癌细胞杀伤效率得到证明。这些发现有望激发策略并为利用PDA构造有机-无机复合纳米载体铺平道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号